GHUCCTS

News

Share This
  • Sept 08, 2022

Georgetown Awarded $23.6M PCORI Grant to Study Treatments for Acute Rhinosinusitis


The Patient-Centered Outcomes Research Institute (PCORI) has awarded Principal Investigator, Dan Merenstein, MD, Professor of Family Medicine at Georgetown’s School of Medicine and Professor of Human Science at the School of Health and Co-Principal Investigator, Nawar M. Shara, PhD, Director of Center of Biostatistics, Informatics and Data Science (CBIDS) at the MedStar Health Research Institute, a $23.6 million research grant to study treatments for acute rhinosinusitis.   Acute rhinosinusitis involves inflammation of the nose and sinus passages, most often caused by a viral or bacterial infection. Together, the investigators will recruit more than 3,700 people diagnosed with acute rhinosinusitis to the largest clinical trial of its kind to study various treatment approaches.  Dr. Merenstein served as part of the GHUCCTS Community Engagement Core for various years and took from this experience to inform the engagement sections of the grant.  Dr. Shara is a long-standing member of the GHUCCTS team serving as Director of BERD and Co-Director of Biomedical Informatics and she provided key input during grant development.  The GHUCCTS Community Engagement Core will take an active role during study implementation by developing and facilitating the study’s Patient Advisory Board. 

Full article: https://gumc.georgetown.edu/news-release/georgetown-awarded-23-6m-to-study-treatments-for-acute-rhinosinusitis/

Related News

2024 KL2 Junior Faculty Scholars Program - Request for Applications

Jun 12, 2024

 We are pleased to announce the next round of Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) KL2 awards with this call for new applications. Full applications will be due on August 5, 2024.

Registration is open for the Summer Intensive Workshop: Biostatistics, Epidemiology, and Clinical Research

May 24, 2024

One-week introductory-level workshop with a focus on Biostatistics & Design of Clinical Trials.

The ​2024-2025 Association for Clinical and Translational Science (ACTS)​ ​Board of Directors Election has shared its results.​

Apr 25, 2024

ACTS​ ​is pleased to announce the results of their recent elections for Director-at-Large and officer positions on the board of directors.​ With a member from our GHUCCTS community.

Close